EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans

Jonas Henrik Kristensen iD, Rasmus Bo Hasselbalch iD, Nina Strandkjær iD, Nicoline Jørgensen, Morten Østergaard, Peter Hasse Møller-Sørensen iD, Jens Christian Nilsson iD, Shoaib Afzal iD, Pia Rørbæk Kamstrup iD, Morten Dahl iD, Mustafa Vakur Bor, Ruth Frikke-Schmidt iD und 11 weitere

Circulation · 2024

DOI: 10.1161/circulationaha.123.066565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, 2024. Verfasst von Jonas Henrik Kristensen und 22 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Cardiology (J.H.K., R.B.H., N.S., N.J., K.K.I.), Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark. Hauptthemen laut MEDLINE: Troponin I, Troponin T, Myocardial Infarction. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardiac troponin (cTn) is key in diagnosing myocardial infarction (MI). After MI, the clinically observed half-life of cTn has been reported to be 7 to 20 hours, but this estimate reflects the combined elimination and simultaneous release of cTn from cardiomyocytes. More precise timing of myocardial injuries necessitates separation of these 2 components. We used a novel method for determination of isolated cTn elimination kinetics in humans. METHODS: Patients with MI were included within 24 hours after revascularization and underwent plasmapheresis to obtain plasma with a high cTn concentration. After at least 3 weeks, patients returned for an autologous plasma retransfusion followed by blood sampling for 8 hours. cTn was measured with 5 different high-sensitivity cTn assays. RESULTS: Of 25 included patients, 20 participants (mean age, 64.5 years; SD, 8.2 years; 4 women [20%]) received a retransfusion after a median of 5.8 weeks (interquartile range, 5.0–6.9 weeks) after MI. After retransfusion of a median of 620 mL (range, 180–679 mL) autologous plasma, the concentration of cTn in participants’ blood increased 4 to 445 times above the upper reference level of the 5 high-sensitivity cTn assays. The median elimination half-life ranged from 134.1 minutes (95% CI, 117.8–168.0) for the Elecsys high-sensitivity cTnT assay to 239.7 minutes (95% CI, 153.7–295.1) for the Vitros high-sensitivity cTnI assay. The median clearance of cTnI ranged from 40.3 mL/min (95% CI, 32.0–44.9) to 52.7 mL/min (95% CI, 42.2–57.8). The clearance of cTnT was 77.0 mL/min (95% CI, 45.2–95.0). CONCLUSIONS: This novel method showed that the elimination half-life of cTnI and cTnT was 5 to 16 hours shorter than previously reported. This indicates a considerably longer duration of cardiomyocyte cTn release after MI than previously thought. Improved knowledge of timing of myocardial injury may call for changes in the management of MI and other disorders with myocardial injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Troponin ITroponin TMyocardial InfarctionHumansFemaleMaleMiddle AgedHalf-LifeAgedBiomarkersPlasmapheresis

Stichwörter der Autor:innen

biomarkersmyocardial infarctionpharmacokineticstroponin

Substanzen

Troponin ITroponin TBiomarkers

Autor:innen und Institutionen

  • Departments of Cardiology (J.H.K., R.B.H., N.S., N.J., K.K.I.), Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Emergency Medicine (J.H.K., R.B.H., N.S., N.J., K.K.I.), Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Department of Clinical Medicine (J.H.K., R.B.H., N.S., S.A., M.D., N.R.J., J.K., K.D., H.B., K.K.I.), University of Copenhagen, Denmark.
  • Cardiothoracic Anaesthesiology (M.Ø. P.H.M.-S., J.C.N.), Copenhagen University Hospital-Rigshospitalet, Denmark.
  • Clinical Biochemistry (S.A., P.R.K.), Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Department of Clinical Biochemistry, Zealand University Hospital-Køge, Denmark (M.D.).

ORCID-Profile: Jonas Henrik Kristensen, Rasmus Bo Hasselbalch, Nina Strandkjær, Peter Hasse Møller-Sørensen, Jens Christian Nilsson, Shoaib Afzal, Pia Rørbæk Kamstrup, Morten Dahl, Ruth Frikke-Schmidt, Niklas Rye Jørgensen, Line Rode, Jesper Kjærgaard, Julie Forman, Kim Dalhoff, Allan S Jaffe, Henning Bundgaard, Kasper Karmark Iversen

Zitieren

APA

Kristensen, J. H., Hasselbalch, R. B., Strandkjær, N., Jørgensen, N., Østergaard, M., Møller-Sørensen, P. H., Nilsson, J. C., Afzal, S., Kamstrup, P. R., Dahl, M., Bor, M. V., Frikke-Schmidt, R., Jørgensen, N. R., Rode, L., Holmvang, L., Kjærgaard, J., Bang, L. E., Forman, J., Dalhoff, K., …, & Iversen, K. K. (2024). Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans. Circulation. https://doi.org/10.1161/circulationaha.123.066565

Vancouver

Kristensen JH, Hasselbalch RB, Strandkjær N, Jørgensen N, Østergaard M, Møller-Sørensen PH, et al. Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans. Circulation. 2024. doi:10.1161/circulationaha.123.066565

BibTeX
@article{Kristensen2024,
  author = {Kristensen, Jonas Henrik and Hasselbalch, Rasmus Bo and Strandkjær, Nina and Jørgensen, Nicoline and Østergaard, Morten and Møller-Sørensen, Peter Hasse and Nilsson, Jens Christian and Afzal, Shoaib and Kamstrup, Pia Rørbæk and Dahl, Morten and Bor, Mustafa Vakur and Frikke-Schmidt, Ruth and Jørgensen, Niklas Rye and Rode, Line and Holmvang, Lene and Kjærgaard, Jesper and Bang, Lia Evi and Forman, Julie and Dalhoff, Kim and Jaffe, Allan S and Thygesen, Kristian and Bundgaard, Henning and Iversen, Kasper Karmark},
  title = {Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans},
  journal = {Circulation},
  year = {2024},
  doi = {10.1161/circulationaha.123.066565}
}
Kostenlos starten →